News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ryan Charles S.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/03/2020 |
4
| Ryan Charles S. (10% Owner) has filed a Form 4 on Neurotrope, Inc.|
Txns:
| Disposed/sold 157,918 options to buy
@ $7.55, valued at
$1.2M
Disposed/sold 79,097 options to buy
@ $4.37, valued at
$345.7k
Disposed/sold 150,000 options to buy
@ $3.93, valued at
$589.5k
Disposed/sold 130,680 options to buy
@ $0.7825, valued at
$102.3k
Disposed/sold 40,000 options to buy
@ $0.972, valued at
$38.9k
|
|
| 11/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2019 |
4
| Ryan Charles S. (CEO) has filed a Form 4 on Neurotrope, Inc.|
Txns:
| Granted 130,680 options to buy
@ $0.7825, valued at
$102.3k
|
|
| 05/21/2019 |
4
| Ryan Charles S. (Director) has filed a Form 4 on APPLIED DNA SCIENCES INC|
Txns:
| Granted 175,435 options to buy
@ $0.56, valued at
$98.2k
|
|
| 03/25/2019 |
4
| Ryan Charles S. (Director) has filed a Form 4 on BioRestorative Therapies, Inc.|
Txns:
| Disposed/sold 15,000 options
@ $4.7, valued at
$70.5k
Granted 15,000 options
@ $0.75, valued at
$11.3k
Disposed/sold 20,000 options
@ $4.7, valued at
$94k
Granted 20,000 options
@ $0.75, valued at
$15k
Disposed/sold 46,000 options
@ $3.73, valued at
$171.6k
Granted 46,000 options
@ $0.75, valued at
$34.5k
Disposed/sold 100,000 options
@ $3.35, valued at
$335k
Granted 100,000 options
@ $0.75, valued at
$75k
Disposed/sold 75,000 options
@ $1.23, valued at
$92.3k
Granted 75,000 options
@ $0.75, valued at
$56.3k
|
|
| 01/24/2019 |
4
| Ryan Charles S. (CEO) has filed a Form 4 on Neurotrope, Inc.|
Txns:
| Granted 150,000 options to buy
@ $3.93, valued at
$589.5k
|
|
| 12/17/2018 |
4
| Ryan Charles S. (CEO) has filed a Form 4 on Neurotrope, Inc.|
Txns:
| Granted 79,097 options to buy
@ $4.37, valued at
$345.7k
|
|
| 10/31/2018 |
4
| Ryan Charles S. (Director) has filed a Form 4 on BioRestorative Therapies, Inc.|
Txns:
| Granted 75,000 options
@ $1.23, valued at
$92.3k
|
|
| 10/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2018 |
4
| Ryan Charles S. (Director) has filed a Form 4 on APPLIED DNA SCIENCES INC|
Txns:
| Granted 63,919 options to buy
@ $1.57, valued at
$100.4k
Granted 7,204 options to buy
@ $1.57, valued at
$11.3k
|
|
| 12/18/2017 |
4
| Ryan Charles S. (Director) has filed a Form 4 on Neurotrope, Inc.|
Txns:
| Granted 157,918 options to buy
@ $7.55, valued at
$1.2M
|
|
| 12/18/2017 |
3
| Ryan Charles S. (Director) has filed a Form 3 on Neurotrope, Inc. |
| 06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|